Featured Research

from universities, journals, and other organizations

Is glaucoma a brain disease? Scientists find that jigsaw effect in glaucoma patients proves it is

Date:
June 5, 2014
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Summary:
The brain, not the eye, controls the cellular process that leads to glaucoma, a new study finds. The results may help develop treatments for one of the world’s leading causes of irreversible blindness, as well as contribute to the development of future therapies for preserving brain function in other age-related disorders such as Alzheimer’s.

Eye check (stock image). According to the researchers, the cellular process used for pruning small optic nerve axons in glaucoma is "remarkably similar to the apoptotic mechanism that operates in the brains of people afflicted with Alzheimer's disease."
Credit: Monkey Business / Fotolia

Findings from a new study published in Translational Vision Science & Technology (TVST) show the brain, not the eye, controls the cellular process that leads to glaucoma. The results may help develop treatments for one of the world's leading causes of irreversible blindness, as well as contribute to the development of future therapies for preserving brain function in other age-related disorders such as Alzheimer's.

In the TVST paper, "Refined Data Analysis Provides Clinical Evidence for Central Nervous System Control of Chronic Glaucomatous Neurodegeneration," vision scientists and ophthalmologists describe how they performed a data and symmetry analysis of 47 patients with moderate to severe glaucoma in both eyes. In glaucoma, the loss of vision in each eye appears to be haphazard. Conversely, neural damage within the brain caused by strokes or tumors produces visual field loss that is almost identical for each eye, supporting the idea that the entire degenerative process in glaucoma must occur at random in the individual eye -- without brain involvement.

However, the team of investigators discovered during their analysis that as previously disabled optic nerve axons -- that can lead to vision loss -- recover, the remaining areas of permanent visual loss in one eye coincide with the areas that can still see in the other eye. The team found that the visual field of the two eyes fit together like a jigsaw puzzle, resulting in much better vision with both eyes open than could possibly arise by chance.

"As age and other insults to ocular health take their toll on each eye, discrete bundles of the small axons within the larger optic nerve are sacrificed so the rest of the axons can continue to carry sight information to the brain," explains author William Eric Sponsel, MD, of the University of Texas at San Antonio, Department of Biomedical Engineering. "This quiet intentional sacrifice of some wires to save the rest, when there are decreasing resources to support them all (called apoptosis), is analogous to pruning some of the limbs on a stressed fruit tree so the other branches can continue to bear healthy fruit."

According to the researchers, the cellular process used for pruning small optic nerve axons in glaucoma is "remarkably similar to the apoptotic mechanism that operates in the brains of people afflicted with Alzheimer's disease."

"The extent and statistical strength of the jigsaw effect in conserving the binocular visual field among the clinical population turned out to be remarkably strong," said Sponsel. "The entire phenomenon appears to be under the meticulous control of the brain."

The TVST paper is the first evidence in humans that the brain plays a part in pruning optic nerve axon cells. In a previous study, "Failure of Axonal Transport Induces a Spatially Coincident Increase in Astrocyte BDNF Prior to Synapse Loss in a Central Target," a mouse model suggested the possibility that following injury to the optic nerve cells in the eye, the brain controlled a pruning of those cells at its end of the nerve. This ultimately caused the injured cells to die.

"Our basic science work has demonstrated that axons undergo functional deficits in transport at central brain sites well before any structural loss of axons," said David J. Calkins, PhD, of the Vanderbilt Eye Institute and author of the previous study. "Indeed, we found no evidence of actual pruning of axon synapses until much, much later. Similarly, projection neurons in the brain persisted much longer, as well."

"This is consistent with the partial recovery of more diffuse overlapping visual field defects observed by Dr. Sponsel that helped unmask the more permanent interlocking jigsaw patterns once the eyes of his severely affected patients had been surgically stabilized," said Calkins.

Sponsel has already seen how these findings have positively affected surgically stabilized patients who were previously worried about going blind. "When shown the complementarity of their isolated right and left eye visual fields, they become far less perplexed and more reassured," he said. "It would be relatively straightforward to modify existing equipment to allow for the performance of simultaneous binocular visual fields in addition to standard right eye and left eye testing.

Authors of the TVST paper suggest their findings can assist in future research with cellular processes similar to the one used for pruning small optic nerve axons in glaucoma, such as occurs in the brains of individuals affected by Alzheimer's.

"If the brain is actively trying to maintain the best binocular field, and not just producing the jigsaw effect accidentally, that would imply some neuro-protective substance is at work preventing unwanted pruning," said co-author of the TVST paper Ted Maddess, PhD, of the ARC Centre of Excellence in Vision Science, Australian National University. "Since glaucoma has much in common with other important neurodegenerative disorders, our research may say something generally about connections of other nerves within the brain and what controls their maintenance."


Story Source:

The above story is based on materials provided by Association for Research in Vision and Ophthalmology (ARVO). Note: Materials may be edited for content and length.


Journal Reference:

  1. William E. Sponsel, Sylvia L. Groth, Nancy Satsangi, Ted Maddess, Matthew A. Reilly. Refined Data Analysis Provides Clinical Evidence for Central Nervous System Control of Chronic Glaucomatous Neurodegeneration. Translational Vision Science & Technology, 2014; 3 (3): 1 DOI: 10.1167/tvst.3.3.1

Cite This Page:

Association for Research in Vision and Ophthalmology (ARVO). "Is glaucoma a brain disease? Scientists find that jigsaw effect in glaucoma patients proves it is." ScienceDaily. ScienceDaily, 5 June 2014. <www.sciencedaily.com/releases/2014/06/140605213129.htm>.
Association for Research in Vision and Ophthalmology (ARVO). (2014, June 5). Is glaucoma a brain disease? Scientists find that jigsaw effect in glaucoma patients proves it is. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2014/06/140605213129.htm
Association for Research in Vision and Ophthalmology (ARVO). "Is glaucoma a brain disease? Scientists find that jigsaw effect in glaucoma patients proves it is." ScienceDaily. www.sciencedaily.com/releases/2014/06/140605213129.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins